Elicio Therapeutics (ELTX) announced the appointment of Marc Wolfgang, M.S. as Chief Technology Officer. He most recently served as Senior Vice President of Technical Development and Operations at Sail Biomedicines.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELTX:
- Elicio Therapeutics Reports Q3 2025 Financial Results
- Elicio Therapeutics files to sell 103,225 shares of common stock for holders
- Elicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
- Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
- Elicio Therapeutics announces investigator-initiated Phase 1 trial of ELI-002 7P